1283602

Lily C. Chao, M.D. — FEI 3023087883

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance